EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies

Yujiao Zeng, Yuting Luo, Lijie Wang, Kun Zhang, Jiayan Peng, Gang Fan iD

International Journal of Molecular Sciences · 07.02.2023 · 24 (4) · 3323

DOI: 10.3390/ijms24043323 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.02.2023. Verfasst von Yujiao Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 6111…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Curcumin, Non-alcoholic Fatty Liver Disease, Metabolic Diseases. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Research and Development Program of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic diseases have become a serious threat to human health worldwide. It is crucial to look for effective drugs from natural products to treat metabolic diseases. Curcumin, a natural polyphenolic compound, is mainly obtained from the rhizomes of the genus Curcuma. In recent years, clinical trials using curcumin for the treatment of metabolic diseases have been increasing. In this review, we provide a timely and comprehensive summary of the clinical progress of curcumin in the treatment of three metabolic diseases, namely type 2 diabetes mellitus (T2DM), obesity and non-alcoholic fatty liver disease (NAFLD). The therapeutic effects and underlying mechanisms of curcumin on these three diseases are presented categorically. Accumulating clinical evidence demonstrates that curcumin has good therapeutic potential and a low number of side effects for the three metabolic diseases. It can lower blood glucose and lipid levels, improve insulin resistance and reduce inflammation and oxidative stress. Overall, curcumin may be an effective drug for the treatment of T2DM, obesity and NAFLD. However, more high-quality clinical trials are still required in the future to verify its efficacy and determine its molecular mechanisms and targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2CurcuminNon-alcoholic Fatty Liver DiseaseMetabolic DiseasesHumansObesity

Stichwörter der Autor:innen

clinical evidencecurcumindiabetesnon-alcoholic fatty liver diseaseobesity

Substanzen

Curcumin

Autor:innen und Institutionen

  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

ORCID-Profile: Gang Fan

Förderung

  • the Key Research and Development Program of Sichuan Province

Zitieren

APA

Zeng, Y., Luo, Y., Wang, L., Zhang, K., Peng, J., & Fan, G. (2023). Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies. International Journal of Molecular Sciences, 24(4), 3323. https://doi.org/10.3390/ijms24043323

Vancouver

Zeng Y, Luo Y, Wang L, Zhang K, Peng J, Fan G. Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies. International Journal of Molecular Sciences. 2023;24(4):3323. doi:10.3390/ijms24043323

BibTeX
@article{Zeng2023,
  author = {Zeng, Yujiao and Luo, Yuting and Wang, Lijie and Zhang, Kun and Peng, Jiayan and Fan, Gang},
  title = {Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3323},
  doi = {10.3390/ijms24043323}
}
Kostenlos starten →